19 results
424B5
CGTX
Cognition Therapeutics Inc
13 Mar 24
Prospectus supplement for primary offering
4:04pm
and restated bylaws, procedures for our stockholder meetings, the classified board, director liability, and exclusive forum for proceedings.
Dividends. Subject
424B5
CGTX
Cognition Therapeutics Inc
11 Mar 24
Prospectus supplement for primary offering
4:06pm
stockholder meetings, the classified board, director liability, and exclusive forum for proceedings.
Dividends. Subject to preferences that may
424B4
CGTX
Cognition Therapeutics Inc
8 Jan 24
Prospectus supplement with pricing info
4:11pm
, the classified board, director liability, and exclusive forum for proceedings.
Dividends. Subject to preferences that may be applicable to any
S-3
3hvqopb506u9vcu58g2
23 Dec 22
Shelf registration
4:16pm
424B4
o51rqz2qtd4imgkgj
14 Nov 22
Prospectus supplement with pricing info
6:02am
DRS
ommx0i9cg2jjp1npbh
20 Oct 22
Draft registration statement
12:00am
10-K
ntpyl
30 Mar 22
Annual report
7:40am
10-Q
jyvkqprn3f
17 Nov 21
Quarterly report
5:15pm
8-K
7cjo6it78 pccr88
14 Oct 21
Amendments to Articles of Incorporation or Bylaws
4:41pm
424B4
b7ekiverepud
12 Oct 21
Prospectus supplement with pricing info
4:11pm
S-1
zc9ur1i
19 Jul 21
IPO registration
7:02am
DRS/A
3txowsacoyu
23 Jun 21
Draft registration statement (amended)
12:00am
DRS
yru34el w9
7 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next